Lv4
570 积分 2022-07-29 加入
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
10个月前
已完结
Bispecific antibodies: a mechanistic review of the pipeline
11个月前
已完结
The present and future of bispecific antibodies for cancer therapy
11个月前
已完结
Strategies for delivering therapeutics across the blood–brain barrier
1年前
已完结
Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update
1年前
已完结
Immune-related generalised oedema – A new category of adverse events with immune checkpoint inhibitors
1年前
已完结
Dual CTLA‐4 and PD‐1 checkpoint blockade using CS1002 and CS1003 (nofazinlimab) in patients with advanced solid tumors: A first‐in‐human, dose‐escalation, and dose‐expansion study
1年前
已关闭
Optimization of Protein and Peptide Drugs Based on the Mechanisms of Kidney Clearance
1年前
已关闭
Excessive salt intake reduces bone density in the general female population
1年前
已完结
KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells
1年前
已完结
皖公网安备34019202002308
